Pay in 4 interest-free payments of $5.03 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Products Related to the GCGR Target Dima Biotechnology is a biotechnology company specializing in preclinical research products and services for druggable targets
In vitro cellular uptake and insulin secretion studies on INS-1E cells of exendin-4-loaded self-nanoemulsifying drug delivery systems
Patent protections for semaglutide (Ozempic/Wegovy) expire in 2026 in Canada, India, Brazil and China, opening the door for lower-cost biosimilar generic versions
On the one hand, it is the pressure from biosimilars, Jiuyuan Gene and Xinbei River Pharmaceutical, which are in line at the NMPA, submitted the registration application for Semaglutide even earlier than Qilu Pharmaceutical
US$ 24.89
US$ 27.33
US$ 23.89
US$ 25.61
US$ 27.46
US$ 23.68
US$ 26.10
